Old Web
English
Sign In
Acemap
>
authorDetail
>
Richard G. Ghalie
Richard G. Ghalie
University of Texas MD Anderson Cancer Center
Medicine
Follicular lymphoma
Rituximab
Immunology
Placebo
4
Papers
142
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase 2 trial of immunotherapy with mitumprotimut-T (Id-KLH) and GM-CSF following rituximab in follicular B-cell lymphoma.
2010
Journal of Immunotherapy
Omer N. Koc
Charles H. Redfern
Peter H. Wiernik
Fred Rosenfelt
Jane N. Winter
William D. Carter
Dan P. Gold
Morgan E. Stewart
Richard G. Ghalie
John F. Bender
Show All
Source
Cite
Save
Citations (8)
A Placebo-Controlled Phase III Trial of Patient-Specific Immunotherapy with Mitumprotimut-T (ID-KLH) and GM-CSF Following Rituximab in Patients with CD20+ Follicular Lymphoma
2008
Blood
Arnold S. Freedman
Sattva S. Neelapu
Craig R Nichols
Michael Robertson
Benjamin Djulbegovic
Jane N. Winter
Daniel P. Gold
John Bender
Morgan E. Stewart
Richard G. Ghalie
Paul A. Hamlin
Show All
Source
Cite
Save
Citations (10)
Secondary Leukemia After Adjuvant Chemotherapy for Breast Cancer
2001
Journal of Clinical Oncology
Richard G. Ghalie
Donald E. Goodkin
Claire Bonithon-Kopp
Milan C
Gilles Chaplain
Catherine Sgro
Paule‐Marie Carli
Show All
Source
Cite
Save
Citations (4)
1